Metropolitan Life Insurance Company (MetLife)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-17,857	Closed	-$1.74M	–	2737
2015 Q1	$1.74M	Buy	17,857 +1,272	+8%	+$135K	0.01%	935
2014 Q4	$1.54M	Hold	16,585	–	–	0.01%	1076
2014 Q3	$1.14M	Hold	16,585	–	–	0.01%	1196
2014 Q2	$1.74M	Buy	16,585 +863	+5%	+$73.4K	0.01%	1052
2014 Q1	$1.3M	Hold	15,722	–	–	0.01%	1168
2013 Q4	$1.02M	Buy	15,722 +1,863	+13%	+$111K	0.01%	1318
2013 Q3	$877K	Hold	13,859	–	–	0.01%	1357
2013 Q2	$582K	Buy	+13,859	New	+$632K	﹤0.01%	1600

Metropolitan Life Insurance Company (MetLife)'s GEVA Position: Q2 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 17,857 shares — an estimated $1.74M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.74M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Metropolitan Life Insurance Company (MetLife) reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 17,857 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.74M.
Metropolitan Life Insurance Company (MetLife) first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.74M in Q1 2015.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2015, filed 17 Aug 2015.